Literature DB >> 14977939

Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs.

Shannon Sedberry Allen1, Lynne Cassone, Todd M Lasco, David N McMurray.   

Abstract

Transforming growth factor beta (TGF-beta) is a cytokine which has been shown to suppress the antimycobacterial immune responses of humans and experimental animals. In this study, the contributions of TGF-beta to cytokine production in vivo were investigated by using the established guinea pig model of tuberculous pleurisy. Mycobacterium bovis BCG-vaccinated guinea pigs were injected intrapleurally with heat-killed virulent Mycobacterium tuberculosis. Eight days following induction of an antigen-specific pleural effusion, guinea pigs were injected intrapleurally with anti-TGF-beta1 or isotype control antibody. The following day, pleural exudates were removed, and the fluid volume and characteristics of the infiltrating cells were determined. Pleural fluid was analyzed for total interferon (IFN) and tumor necrosis factor (TNF) protein levels by using appropriate bioassays. RNA from pleural effusion cells was examined to determine TGF-beta1, TNF-alpha, IFN-gamma, and interleukin-8 mRNA levels by using real-time PCR. Proliferative responses of pleural effusion lymphocytes were examined in response to concanavalin A and purified protein derivative (PPD) in vitro. Treatment with anti-TGF-beta1 resulted in decreased pleural fluid volume and decreased cell numbers in the pleural space along with an increased percentage of lymphocytes and a decreased percentage of neutrophils. The bioactive TNF protein levels in pleural fluid were increased in guinea pigs treated with anti-TGF-beta1, while the bioactive IFN protein concentrations were not altered. Expression of TGF-beta1 and TNF-alpha mRNA was significantly increased following TGF-beta1 neutralization. Finally, PPD-induced proliferative responses of pleural cells from anti-TGF-beta1-treated animals were significantly enhanced. Thus, TGF-beta1 may be involved in the resolution of this local, mycobacterial antigen-specific inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977939      PMCID: PMC356004          DOI: 10.1128/IAI.72.3.1358-1363.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells.

Authors:  M Turner; D Chantry; M Feldmann
Journal:  Cytokine       Date:  1990-05       Impact factor: 3.861

2.  Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts.

Authors:  J O Olobo; M Geletu; A Demissie; T Eguale; K Hiwot; G Aderaye; S Britton
Journal:  Scand J Immunol       Date:  2001-01       Impact factor: 3.487

3.  Enhancement of human neutrophil survival and activation by TGF-beta 1.

Authors:  M Lagraoui; L Gagnon
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1997-05       Impact factor: 1.770

4.  Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs.

Authors:  M K Cohen; R A Bartow; C L Mintzer; D N McMurray
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

5.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

6.  A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits.

Authors:  R W Light; D S Cheng; Y C Lee; J Rogers; J Davidson; K B Lane
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

7.  Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes.

Authors:  F De Ceuninck; P Pastoureau; F Bouet; J Bonnet; P M Vanhoutte
Journal:  J Cell Biochem       Date:  1998-06-15       Impact factor: 4.429

8.  Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.

Authors:  M E Brandes; U E Mai; K Ohura; S M Wahl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  A new assay system for guinea pig interferon biological activity.

Authors:  Toshiko Yamamoto; Amminikutty Jeevan; Kazue Ohishi; Yasuhiro Nojima; Kiyoko Umemori; Saburo Yamamoto; David N McMurray
Journal:  J Interferon Cytokine Res       Date:  2002-07       Impact factor: 2.607

10.  Pleurisy induced by intrapleural BCG in immunized guinea pigs.

Authors:  O Widström; B S Nilsson
Journal:  Eur J Respir Dis       Date:  1982-09
View more
  11 in total

1.  Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice.

Authors:  Adrian G Rosas-Taraco; David M Higgins; Joaquín Sánchez-Campillo; Eric J Lee; Ian M Orme; Mercedes González-Juarrero
Journal:  Tuberculosis (Edinb)       Date:  2010-12-31       Impact factor: 3.131

2.  Histopathological features and expression profiles of cytokines, chemokines and SOCS family proteins in trehalose 6,6'-dimycolate-induced granulomatous lesions.

Authors:  Yusuke Sakai; Kazuyuki Uchida; Hiroyuki Nakayama
Journal:  Inflamm Res       Date:  2010-11-26       Impact factor: 4.575

Review 3.  Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Authors:  C Sander; H McShane
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis.

Authors:  Lan H Ly; Amminikutty Jeevan; David N McMurray
Journal:  Microbes Infect       Date:  2009-04-21       Impact factor: 2.700

5.  Latent TGF-beta1 protects against crescentic glomerulonephritis.

Authors:  Xiao R Huang; Arthur C K Chung; Li Zhou; Xiao J Wang; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

6.  Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Authors:  Ajay Grover; Jennifer Taylor; JoLynn Troudt; Andrew Keyser; Kimberly Arnett; Linda Izzo; Drew Rholl; Angelo Izzo
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

Review 7.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

8.  Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Authors:  Payam Nahid; Erin Bliven-Sizemore; Leah G Jarlsberg; Mary A De Groote; John L Johnson; Grace Muzanyi; Melissa Engle; Marc Weiner; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  Tuberculosis (Edinb)       Date:  2014-02-07       Impact factor: 3.131

9.  Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs.

Authors:  In Soon Roh; Sungae Cho; Seok-Yong Eum; Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

10.  IL-10 modulates in vitro multinucleate giant cell formation in human tuberculosis.

Authors:  Parul Shrivastava; Tamishraha Bagchi
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.